Document:

REGISTRATION
      RIGHTS AGREEMENT 

    

    THIS
      REGISTRATION RIGHTS AGREEMENT (this
      “Agreement”), dated as of this ______day
      of
      ___________ 200_____,
      is by and between Herborium Group, Inc., a Delaware Corporation (the “Company”),
      and the person whose name appears on the signature page attached hereto
      (individually a “Holder” and collectively, with the holders of other securities
      issued in the Offering (as defined below), the “Holders”).

     

    WHEREAS,
      pursuant to a Subscription Agreement the Company has offered (the “Offering”) to
      sell up to $500,000 in 10% promissory notes (the “Notes”), convertible into
      shares of the Company’s common stock (the “Shares” or the “Common Stock”), each
      $50,000 in Notes also includes the issuance of 50,000 shares of Common Stock
      and
      the issuance of five year warrants to purchase 100,000 shares of Common Stock,
      or like security issued in a Qualified Financing or Acquisition, 50,000 at
      an
      exercise price of $0.025 per share and 50,000 at an exercise price of $0.05
      (the
“Warrants” along with the Notes and Common Stock per $50,000 investment, (a
“Unit”)). Through an over-allotment option, the Company may elect to sell up to
      an additional 5 Units in the Offering for a total of $250,000;

     

    WHEREAS,
      pursuant
      to the terms of and in order to induce the Holders to enter into a certain
      Subscription Agreement between the Company and the Holder (the “Subscription
      Agreement”) to purchase the Units, the Company and each Holder have agreed to
      enter into this Agreement setting forth the registration rights to be granted
      with respect to the shares of Common Stock issued, or issueable to each holder
      upon conversion of the Notes and/or Warrants, issued to each Holder pursuant
      to
      the Subscription Agreements (the “Registrable Securities”); and

    

    WHEREAS,
      it is
      intended by the Company and the Holders that this Agreement shall become
      effective immediately upon the acquisition by the Holders of the
      Units;

    

    NOW,
      THEREFORE,
      in
      consideration of the premises and the mutual covenants contained herein and
      in
      the Subscription Agreement, the Company and the Holder hereby agree as
      follows:

    

    1. Registration
      Rights

     

    (a)
      Piggyback
      Registration Rights.
      If the
      Company at any time proposes to register any of its equity securities under
      the
      Securities Act of 1933, as amended (the “1933 Act”), for sale to the public,
      whether for its own account or for the account of other security holders or
      both
      (except with respect to registration statements on Forms S-4 or S-8 or another
      form not available for registering the Registrable Securities for sale to the
      public, a registration statement on Form S-3 to be filed by the Company to
      register securities issued in consideration for an acquisition, a registration
      statement on Form S-1 covering solely an employee benefit plan or a registration
      statement relating to a dividend reinvestment plan), it will give written notice
      at such time to each Holder. Upon the written request of each Holder, given
      within twenty (20) days after receipt of any such notice by the Company, to
      register any of its Registrable Securities (which request shall state the
      intended method of disposition thereof), the Company will use its best efforts
      to cause the Registrable Securities as to which registration shall have been
      so
      requested, to be included in the securities to be covered by the registration
      statement proposed to be filed by the Company, all to the extent requisite
      to
      permit the sale or other disposition by the Holder (in accordance with its
      written request); provided
      that
      nothing herein shall prevent the Company from abandoning or delaying any such
      registration at any time. In the event that any registration pursuant to this
      Section 1(a) shall be, in whole or in part, an underwritten public offering
      of
      equity securities, any request by a Holder pursuant to this Section 1(a) to
      register Registrable Securities shall specify that such Registrable Securities
      are to be included in the underwriting on the same terms and conditions as
      the
      equity securities otherwise being sold through underwriters under such
      registration. The number of shares of Registrable Securities to be included
      in
      such an underwriting may be reduced (pro rata
      among
      all persons or entities having registration rights), if and to be the extent
      that the managing underwriter shall be of the opinion that such inclusion would
      adversely affect the marketing of the securities to be sold by the Company
      therein; provided,
      however
      that
      except in the case of the Company's initial public offering of Common Stock
      (in
      which the number of shares to be offered on behalf of selling shareholders
      may
      be reduced to zero) or in the case of an underwritten offering of an equity
      security other than Common Stock (in which the number of shares to be offered
      on
      behalf of selling shareholders may also be reduced to zero), in no event shall
      the number of shares to be registered on behalf of selling Holders be less
      than
      twenty percent (20%) of the aggregate number of shares to be offered in such
      underwriting. If the offering covered by this Section 1(a) shall be an
      underwritten public offering, the Company shall designate the managing
      underwriter of such offering. In the event of any such reduction or cutback
      in
      the number of Registrable Securities to be registered, or in the event that
      the
      Company abandons any such registration prior to the effective date thereof,
      the
      Holders shall continue to maintain the rights provided by this Section 1,
      subject to the termination provisions of this Agreement.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (b) Cooperation
      with the Company.
      The
      Holders will cooperate with the Company in all respects in connection with
      this
      Agreement, including timely supplying all information reasonably requested
      by
      the Company and executing and returning all documents reasonably requested
      in
      connection with the registration and sale of the Registrable
      Securities.

    

    2. Registration
      Procedures.
      If and
      whenever the Company is required by any of the provisions of this Agreement
      to
      use its commercially reasonable best efforts to effect the registration of
      any
      of the Registrable Securities under the 1933 Act, the Company shall (except
      as
      otherwise provided in this Agreement), as expeditiously as
      possible:

    

    (a) prepare
      and file with the Securities and Exchange Commission (the “Commission”) a
      registration statement and shall use its commercially reasonable best efforts
      to
      cause such registration statement to become effective and remain effective
      until
      (i) all the Registrable Securities covered thereby (the “Covered Securities”)
      are sold or (ii) all Holders (other than “Affiliates” of the Company, as such
      term is defined in Rule 144 under the 1933 Act) are eligible to take advantage
      of the provisions of Rule 144(k) under the 1933 Act with respect to all the
      Registrable Securities (held by persons other than Affiliates) or (iii) two
      years from the date on which such registration statement is declared effective,
      whichever is earliest;

    

    (b) prepare
      and file with the Commission such amendments and supplements to such
      registration statement and the prospectus used in connection therewith as may
      be
      necessary to keep such registration statement effective and to comply with
      the
      provisions of the 1933 Act with respect to the sale or other disposition of
      all
      securities covered by such registration statement;

    

    (c) furnish
      to each Holder of the Covered Securities such numbers of copies of a summary
      prospectus or other prospectus, including a preliminary prospectus or any
      amendment or supplement to any prospectus, in conformity with the requirements
      of the 1933 Act, and such other documents, as such Holder may reasonably request
      in order to facilitate the public sale or other disposition of the securities
      owned by such Holder;

     

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    (d) use
      its
      commercially reasonable best efforts to register and qualify the Covered
      Securities under such other securities or blue sky laws of such jurisdictions
      as
      the Holders of a majority of the Covered Securities shall reasonably request,
      and do any and all other acts and things which may be necessary or advisable
      to
      enable such Holders to consummate the public sale or other disposition in such
      jurisdictions of the Covered Securities owned by such Holders, except that
      the
      Company shall not for any such purpose be required to qualify to do business
      as
      a foreign corporation in any jurisdiction wherein it is not so qualified or
      to
      file therein any general consent to service of process or to submit itself
      to
      taxation in any jurisdiction which otherwise does not have the right to tax
      the
      Company;

    

    (e) use
      its
      commercially reasonable best efforts to list such securities on any securities
      exchange on which any securities of the Company are then listed, if the listing
      of such securities is then permitted under the rules of such exchange;
      and

    

    (f) notify
      each Holder of Covered Securities, at any time when a prospectus relating
      thereto covered by such registration statement is required to be delivered
      under
      the 1933 Act, of the happening of any event of which it has knowledge as a
      result of which the prospectus included in such registration statement, as
      then
      in effect, includes an untrue statement of a material fact or omits to state
      a
      material fact required to be stated therein or necessary to make the statements
      therein not misleading in the light of the circumstances then
      existing.  

    

    3. Withdrawal
      Obligation.
      By
      including any Covered Securities in any registration statement covered hereby,
      each Holder agrees that (x) the Company shall have the right to delay effecting
      any registration covered hereby in order to allow the Company to delay
      disclosure of sensitive information until such time as the Company is otherwise
      required to make such disclosure, and (y) the Holder shall refrain from selling
      any Registrable Securities if requested to do so by the Company, provided that
      (1) such request shall only be made in order to defer disclosure of sensitive
      information until the Company is otherwise required to make such disclosure
      and
      (2) the Holder is not required to refrain from selling for a period of more
      than
      thirty (30) days in any ninety (90) day period.

    

    4. Expenses.
      All
      expenses incurred in any registration of the Holders' Registrable Securities
      under this Agreement shall be paid by the Company, including, without
      limitation, printing expenses, fees and disbursements of counsel for the
      Company, expenses of any audits to which the Company shall agree or which shall
      be necessary to comply with governmental requirements in connection with any
      such registration, all registration and filing fees for the Holders' Registrable
      Securities under federal and State securities laws, and expenses of complying
      with the securities or blue sky laws of any jurisdictions pursuant to Section
      2(d); provided, however, that the Company shall not be liable for (a) any
      discounts or commissions payable to any underwriter; (b) any stock transfer
      taxes incurred with respect to Registrable Securities sold on behalf of the
      Holder thereof; or (c) the fees and expenses of counsel for any
      Holder.

    

    5. Indemnification.
      In the
      event any Registrable Securities are included in a registration statement
      pursuant to this Agreement;

     

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    (a) Company
      Indemnity.
      (i)
      Without limitation of any other indemnity provided to any Holder, either in
      connection with the Offering or otherwise, to the extent permitted by law,
      the
      Company shall indemnify and hold harmless each Holder, the affiliates, counsel,
      officers, directors and partners of each Holder, any underwriter (as defined
      in
      the 1933 Act) for such Holder, and each person, if any, who controls such Holder
      or underwriter (within the meaning of the 1933 Act or the Securities Exchange
      Act of 1934 (the “Exchange Act”) (collectively, the “Indemnified Holders”)),
      against any losses, claims, damages or liabilities (joint or several) to which
      they may become subject under the 1933 Act, the Exchange Act or other federal
      or
      state law (collectively, the “Claims”), insofar as such Claims (or actions in
      respect thereof) arise out of or are based upon any of the following statements,
      omissions or violations (collectively a “Violation”): (A) any untrue statement
      or alleged untrue statement of a material fact contained in such registration
      statement including any preliminary prospectus or final prospectus contained
      therein or any amendments or supplements thereto, (B) the omission or alleged
      omission to state therein a material fact required to be stated therein, or
      necessary to make the statements therein, in the light of the circumstances
      under which they were made, not misleading, or (C) any violation or alleged
      violation by the Company of the 1933 Act, the Exchange Act or any state
      securities law or any rule or regulation promulgated under the 1933 Act, the
      Exchange Act or any state securities law, and the Company shall reimburse each
      such Indemnified Holder for any legal or other expenses incurred by them in
      connection with investigating or defending any such loss, claim, damage,
      liability or action; provided, however, that the Company shall not be liable
      to
      any Indemnified Holder in any such case for any such loss, claim, damage,
      liability or action to the extent that it arises out of or is based upon a
      Violation which occurs in reliance upon and in conformity with written
      information furnished expressly for use in connection with such registration
      statement by or on behalf of any such Indemnified Holder.

    

    (ii) 
      The
      foregoing notwithstanding, the Company shall not be liable to the extent that
      any such Claim arises out of or is based upon a Violation or alleged Violation
      made in any preliminary prospectus if (A) such Indemnified Holder failed to
      send
      or deliver a copy of the prospectus with or prior to the delivery of written
      confirmation of the sale of Registrable Securities giving rise to such Claim
      and
      (B) the prospectus would have corrected such untrue statement or
      omission.

    

    (iii)
      In
      addition, the Company shall not be liable to the extent that any such Claim
      arises out of or is based upon a Violation or alleged Violation in a prospectus,
      (A) if such Violation or alleged Violation is corrected in an amendment or
      supplement to such prospectus and (B) having previously been furnished by or
      on
      behalf of the Company with copies of the prospectus as so amended or
      supplemented, such Indemnified Holder thereafter fails to deliver such
      prospectus as so amended or supplemented prior to or concurrently with the
      sale
      to the person who purchased a Registrable Security from such Indemnified Holder
      and who is asserting such Claim.

    

    (b) Holder
      Indemnity.
      Each
      Holder shall indemnify and hold harmless the Company, its affiliates, its
      counsel, officers, directors, stockholders, representatives and partners, any
      underwriter (as defined in the 1933 Act) and each person, if any, who controls
      the Company or the underwriter (within the meaning of the 1933 Act or the
      Exchange Act), against any Claims (joint or several) to which they may become
      subject under the 1933 Act, the Exchange Act or any state securities law, and
      each such Holder shall reimburse the Company and each such affiliate, counsel,
      officer, director, stockholder, representative or partner, underwriter or
      controlling person for any legal or other expenses incurred by them in
      connection with investigating or defending any such Claim insofar as such Claims
      (or actions and respect thereof) arise out of or are based upon (i) written
      information provided by or on behalf of such Holder to the Company expressly
      for
      inclusion in such registration statement, including any preliminary prospectus
      or final prospectus contained therein or any amendments or supplements thereto
      or (ii) any sale by such Holder after receipt from the Company of the notice
      described in Section 2(f) hereof and prior to acceptance from the Company of
      an
      amended or supplemental prospectus; provided, however, that the maximum amount
      which may be recovered from each Holder pursuant to the indemnification granted
      under clause (i) in this paragraph shall be limited to the amount of proceeds
      received by such Holder from the sale of Registrable Securities by such Holder
      pursuant to such registration statement.

     

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    (c) Notice;
      Right to Defend.
      Promptly after receipt by an indemnified party under this Section 5 of notice
      of
      the commencement of any action (including any governmental action), such
      indemnified party shall, if a claim in respect thereof is to be made against
      any
      indemnifying party under this Section 5, deliver to the indemnifying party
      a
      written notice of the commencement thereof, and the indemnifying party shall
      have the right to participate in and if the indemnifying party agrees in writing
      that it will be responsible for any costs, expenses, judgments, damages and
      losses incurred by the indemnified party with respect to such claim, jointly
      with any other indemnifying party similarly noticed, to assume the defense
      thereof with counsel mutually satisfactory to the parties; provided, however,
      that an indemnified party shall have the right to retain its own counsel, with
      the fees and expenses to be paid by the indemnifying party, if the indemnified
      party reasonably believes that representation of such indemnified party by
      the
      counsel retained by the indemnifying party would be inappropriate due to actual
      or potential differing interests between such indemnified party and any other
      party represented by such counsel in such proceeding. The failure to deliver
      written notice to the indemnifying party within a reasonable time of the
      commencement of any such action shall relieve such indemnifying party of any
      liability to the indemnified party under this Agreement only if and to the
      extent that such failure is prejudicial to its ability to defend such action,
      and the omission so to deliver written notice to the indemnifying party will
      not
      relieve it of any liability that it may have to any indemnified party otherwise
      than under this Agreement; provided, however, that the indemnifying party shall
      not be required to indemnify the indemnified party for the amount of a judgment
      in excess of the amount of any previous settlement offer by the plaintiff that
      was rejected by the indemnified party over the objection of the indemnifying
      party.

    

    If
      an
      indemnified party notifies an indemnifying party in writing that such
      indemnified party elects to employ separate counsel at the expense of the
      indemnifying party as permitted by the provisions of the preceding paragraph,
      the indemnifying party shall not have the right to assume the defense of such
      action or proceeding on behalf of such indemnified party. The foregoing
      notwithstanding, the indemnifying party shall not be liable for the reasonable
      fees and expenses of more than one separate firm of attorneys at any time for
      such indemnified party and any other indemnified parties (which firm shall
      be
      designated in writing by such indemnified parties) in connection with any one
      such action or proceeding or separate but substantially similar or related
      actions or proceedings in the same jurisdiction arising out of the same general
      allegations or circumstances.

    

    Any
      indemnifying party shall not be liable for any settlement of any such action
      or
      proceeding effected without its written consent, which consent shall not be
      unreasonably withheld, but if settled with its written consent, or if there
      be a
      final judgment for the plaintiff in any such action or proceeding, the
      indemnifying party agrees to indemnify and hold harmless such indemnified
      parties from and against any loss or liability by reason of such settlement
      or
      judgment.

    

    (d) Contribution.
      If the
      indemnification provided for in this Agreement is held by a court of competent
      jurisdiction to be unavailable to an indemnified party with respect to any
      Claim
      referred to therein, then the indemnifying party, in lieu of indemnifying such
      indemnified party thereunder, shall contribute to the amount paid or payable
      by
      such indemnified party as a result of such loss, liability, claim, damage or
      expense in such proportion as is appropriate to reflect the relative fault
      of
      the indemnifying party on the one hand and of the indemnified party on the
      other
      hand in connection with the statements or omissions which resulted in such
      loss,
      liability, claim, damage or expense as well as any other relevant equitable
      considerations. The relative fault of the indemnifying party and the indemnified
      party shall be determined by reference to, among other things, whether the
      untrue or alleged untrue statement of a material fact or the omission to state
      a
      material fact relates to information supplied by or on behalf of the
      indemnifying party or by the indemnified party and the parties' relative intent,
      knowledge, access to information and opportunity to correct or prevent such
      statement or omission. Notwithstanding the foregoing, the amount any Holder
      shall be obligated to contribute pursuant to this Agreement (other than as
      described in Section 5(b)(ii) hereof) shall be limited to an amount equal to
      the
      proceeds to such Holder of the Registrable Securities sold pursuant to the
      registration statement which gives rise to such obligation to contribute (less
      the aggregate amount of any damages which the Holder has otherwise been required
      to pay in respect of such Claim or any substantially similar Claim arising
      from
      the sale of such Registrable Securities).

     

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    (e) Survival
      of Indemnity.
      The
      indemnification provided by this Agreement shall be a continuing right to
      indemnification and shall survive the registration and sale of any Registrable
      Securities by any person entitled to indemnification hereunder and the
      expiration or termination of this Agreement. Any purported assignment in
      violation of this provision shall be null and void.

    

    6. Assignment
      of Registration Rights.
      The
      rights of the Holders under this Agreement, including the rights to cause the
      Company to register Registrable Securities, may not be assigned without the
      written prior consent of the Company.

    

    7. Lock-up.
      The
      Holder agrees that in connection with the Company’s initial public offering, if
      any, the Holder shall execute such lock-up agreement as shall be proposed by
      the
      Company’s managing underwriter, provided that such lock-up agreement is no more
      restrictive than the lock-up agreement executed generally by the Company’s
      directors and executive officers.

    

    8. Notices.

    

    (a) All
      communications under this Agreement shall be in writing and shall be mailed
      by
      first class mail, postage prepaid, or telecopied or telexed with confirmation
      of
      receipt or delivered by hand or by overnight delivery service, (i) if to the
      Company at Herborium Group, Inc., 2401 East 23rd
      Street,
      Brooklyn, NY 11231 Attention: Dr. Agnes Olszewski, CEO, or at such other address
      as it may have furnished in writing to the Holders of Registrable Securities
      at
      the time outstanding, or (ii) if to any Holder of any Registrable Securities,
      to
      the address of such Holder as it appears in the stock or warrant ledger of
      the
      Company.

    

    (b) Any
      notice so addressed, when mailed by registered or certified mail shall be deemed
      to be given five days after so mailed, when telecopied or telexed shall be
      deemed to be given when transmitted if transmitted during business hours on
      a
      business day or on the next succeeding business day if transmitted other than
      during business hours on a business day, or when delivered by hand or overnight
      shall be deemed to be given when delivered.

    

    9. Successors
      and Assigns.
      Except
      as otherwise expressly provided herein, this Agreement shall inure to the
      benefit of and be binding upon the successors and permitted assigns of the
      Company and each of the Holders.

    

    10. Amendment
      and Waiver.
      This
      Agreement may be amended, and the observance of any term of this Agreement
      may
      be waived, but only with the written consent of the Company and the Holders
      of
      securities representing a majority of the Registrable Securities; provided,
      however, that no such amendment or waiver shall take away any registration
      right
      of any Holder of Registrable Securities or reduce the amount of reimbursable
      costs to any Holder of Registrable Securities in connection with any
      registration hereunder without the consent of such Holder; further provided,
      however, that without the consent of any other Holder of Registrable Securities,
      any Holder may from time to time enter into one or more agreements amending,
      modifying or waiving the provisions of this Agreement if such action does not
      adversely affect the rights or interest of any other Holder of Registrable
      Securities. No delay on the part of any party in the exercise of any right,
      power or remedy shall operate as a waiver thereof, nor shall any single or
      partial exercise by any party of any right, power or remedy preclude any other
      or further exercise thereof, or the exercise of any other right, power or
      remedy.

     

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    11. Counterparts.
      One or
      more counterparts of this Agreement may be signed by the parties, each of which
      shall be an original but all of which together shall constitute one and the
      same
      instrument.

    

    12. Governing
      Law.
      This
      Agreement shall be construed in accordance with and governed by the internal
      laws of the State of New York, without giving effect to conflicts of law
      principles.

    

    13. Invalidity
      of Provisions.
      If any
      provision of this Agreement is or becomes invalid, illegal or unenforceable
      in
      any respect, the validity, legality and enforceability of the remaining
      provisions contained herein shall not be affected thereby.

    

    14. Pronouns;
      Headings.
      Unless
      the context otherwise requires, all personal pronouns used in this Agreement,
      whether in the masculine, feminine or neuter gender, shall include all other
      genders, and if in the singular shall include the plural, and in the plural,
      the
      singular. The headings in this Agreement are for convenience of reference only
      and shall not be deemed to alter or affect the meaning or interpretation of
      any
      provisions hereof. 

     

    IN
      WITNESS WHEREOF,
      the
      undersigned have executed this Agreement as of first provided above

    
 

    
      	 	
              Herborium
                Group, Inc.

            
	 	 
	 	
               

            
	 	
              By:
                Dr. Agnes Olszewski

            

    

    

    

    [Counterpart
      Signature Page to Follow]

     

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    Counterpart
      Signature Page to Registration Rights Agreement

     

    
      	 	
              HOLDER:

            
	 	 
	 	
               

            
	 	
              By:

            
	 	 
	 	
               

            
	 	
              Print
                Name and Title

            
	 	 
	 	
               

            
	 	
              Principal
                Residence or Executive Office

            

    

    

    
      
        
        

      

      
        8SUBSCRIPTION
      DOCUMENT

     

    AND

     

    ACCREDITED
      INVESTOR QUESTIONNAIRE

     

      
        

      

    

     

    Herborium
      Group, Inc.

     

    Total
      Offering: 

     

    $500,000
      in 10% Convertible Promissory Notes 

    500,000
      shares of Common Stock, and 

    1,000,000
      Warrants

     

    (Offered
      in 10 Units of $50,000 Notes,

    50,000
      Common Shares and 100,000 Warrants)

     

    

    
      	
              Name
                of Purchaser:

            	
               

            	 
	 	 	 
	
              Offering
                Log #:

            	
               

            	 

    

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    Herborium
      Group, Inc. 

    SUBSCRIPTION
      DOCUMENTS 

    Instructions
      to Subscribers for Units

     

    For
      those
      persons and entities who wish to subscribe for Units, set forth below is certain
      information which is intended to enable subscribers to more easily and quickly
      complete the necessary subscription documents.

     

    Subscription
      Agreement: 

     

    Complete
      and sign the signature page for individuals, on page 11, or for organizations,
      on page 12, whichever is appropriate; and

     

    Accredited
      Investor Questions: 

     

    Be
      sure
      to initial the relevant sections of item (2) (d) represented the Accredited
      Investor
      Status, page 4 or 5, whichever is appropriate.

     

    Payment
      for Subscription: 

     

    Payment
      for the number of Units subscribed for should accompany the executed
documents
      described above and should be in the form of a check payable to:

     

    The
      aforementioned documents, executed and completed as described above, must be
      promptly delivered to Southridge Investment Group, LLC, 800 Third Avenue,
      9th
      Floor,
      New York, NY 10022. Attn: Michael J. Byl (i.e.,
      complete, execute and return the Subscription Agreement) together
      with the purchase
      price for the number of Units for which you are subscribing. It is suggested
      that the foregoing
      be sent by Overnight Express or Express Mail.

     

    NOTE:
      If you wish to wire your subscription funds, kindly wire same
      to:

     

    Bank
      Name: 

    ABA#:

    ACCT#:

    Acct
      Name:

    
      
        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    SUBSCRIPTION
      AGREEMENT

    Herborium
      Group, Inc. 

     

    Ladies
      and Gentlemen:

     

    Herborium
      Group, Inc., a Nevada corporation (the "Company"), desires to sell up to 10
      Units, for an aggregate of$500,000 in 10% promissory notes payable semi-annually
      in arrears (“Notes”), convertible into
      shares of the Company’s common stock (the “Shares” or the “Common Stock”), each
      Unit of $50,000 in Notes shall include the issuance of 50,000 shares of Common
      Stock (“Additional Shares”)
      and five year warrants to purchase 100,000 shares of Common Stock with 50,000
      warrant shares at an exercise price of $0.025 per share, and 50,000 warrant
      shares at exercise price of $0.05 (the “Warrants” along with
      the
      Notes and Additional Shares per $50,000 investment, equal one (1) “Unit”) (the
“Offering”). Through
      an over-allotment option, the Company may elect to sell up to additional 10
      Units in the Offering for an additional $500,000. The Notes shall be redeemed
      at
      the earlier of either (i) one year from the date of issuance or; (ii) a
      financing transaction of at least $1,500,000 (the “Qualified Financing”), or
      (iii) the closing of a material acquisition of the Company, whether by merger,
      recapitalization,
      sale of assets or other similar material transaction (an “Acquisition”). At the
Noteholder’s
      option, all, or a portion of, the principal and accrued interest on the Notes
      may be converted into shares of the Company’s Common Stock along with a
      Qualified Financing or Acquisition.
      The number of shares into which the Notes are convertible into will equal the
      quotient
      of the converted principal and interest divided by the price per share issued
      in
      a Qualified
      Financing or Acquisition at a 20% discount. The Notes will also contain an
      automatic principal redemption feature (“Redemption Feature”) which requires the
      Company to escrow five (5%)
      of
      its gross revenues in a separate bank account and redeem the Notes, on a
      semi-annual basis
      until such a time that the total principal of has been repaid. Unless the Notes
      are fully paid off,
      the
      first payment under the Redemption Feature will be due within thirty (“30”) days
      of the 1st
      semi-annual
      anniversary of the Notes and then on a semi-annual basis
      thereafter.

     

    The
      minimum investment is $50,000, although the Company may accept, at its
discretion,
      fractional Units. The Offering will close on or about ___________ (the
“Closing”) but the Company
      may elect, at its discretion to extend the Offering for an additional 60 days.
      The Offering
      is a “best efforts” offering and the Company may use the funds upon acceptance
      of a subscription.
      The
      Company agrees and acknowledges that
      the
      shares of Common Stock underlying the Units shall be registered for resale
      in
      the next Registration
      Statement, unless limited by the Underwriter to a public offering on a pari-pasu
      basis with any limitation to management of the Company. Refer to the attached
      Exhibit A for further Offering
      terms description. The undersigned ("Subscriber") desires to purchase the number
      of Units
      set
      forth on the signature page of this Agreement (the "Agreement"). Accordingly,
      the Company and Subscriber agree as follows:

     

    1. Sale
      and Purchase. Subject
      to the terms and conditions set forth in this Agreement, Subscriber hereby
      tenders the amount set forth on the signature page of this Agreement for the
      purchase of the number of Units set forth on said signature page.

     

    2. Representations,
      Warranties, and Agreements of Subscriber. In
      connection with this
      subscription, Subscriber hereby makes the following representations, warranties,
      and agreements
      and confirms the following understandings, each of which are made or confirmed,
      as the case may be, with respect to Units subscribed for herein:

     

    (a)
      Investment
      Purpose. Subscriber
      is acquiring Units for Subscriber's own account and for investment purposes
      only.

    
      
        
        

      

      
        3

        
          

        

      

      
        
        

      

    

     

    (b)
      Review
      and Evaluation of Information Regarding the Company.

     

    (i) Subscriber
      is familiar with the Company’s financial condition and
      proposed operations. Without limiting the foregoing, the Subscriber acknowledges
      that
      the
      undersigned has reviewed the corporate documents regarding the Company, the
      power point presentation, and the terms of this Offering.

     

    (ii) In
      addition to the foregoing, Subscriber acknowledges that Subscriber
      has conducted, or has been afforded the opportunity to conduct, an investigation
      of the Company and has been offered the opportunity to ask representatives
      of
      the
      Company questions about the Company’s financial condition and proposed
business
      and that Subscriber has obtained such available information as Subscriber has
      requested, to the extent Subscriber has deemed necessary, to permit Subscriber
      to fully evaluate the merits and risks of an investment in the Company.
      Representatives of the Company have answered all inquiries that Subscriber
      has
      put to them concerning the Company and its activities, and the offering and
      sale
      of the Units.

     

    (c)
      Risks.
      Subscriber
      recognizes that the purchase of Units involves a high degree of risk and is
      suitable only for persons of adequate financial means who have no need for
      liquidity in this investment in that (i) Subscriber may not be able to liquidate
      the investment in the event of an emergency; (ii) transferability is limited;
      and (iii) in the event of a disposition, Subscriber could sustain a complete
      loss of the entire investment.

     

    (d)
      Accredited
      Investor Status. Subscriber
      represents that Subscriber is an “accredited investor” as such term is defined
      in Rule 501 of Regulation D promulgated under the Securities Act of 1933,
      amended (the “Securities Act”). Specifically, the Subscriber is (check
      appropriate items):

     

    ____________   
      (i) A
      bank,
      savings and loan association or other similar institution (as defined in
      Sections 3(a)(2) and 3(a)(5)(A) of the Securities Act);

     

    ____________   
      (ii) A
      broker
      or dealer registered pursuant to Section 15 of the Securities Exchange Act
      of
      1934, as amended;

     

    ____________   
      (iii) An
      insurance company (as defined in Section 2(13) of the Securities
      Act);

     

    ____________   
      (iv) An
      investment company registered under the Investment Company
      Act of 1940 (the “Investment Company Act”);

     

    ____________   
      (v) A
      Small
      Business Investment Company licensed by the U.S. Small
      Business Administration under Sections 301(c) or (d) of the Small Business
      Investment Act of
      1958;

     

    ____________   
      (vi) Any
      plan
      established and maintained by a state, its political subdivisions, or any agency
      or instrumentality of a state or its subdivisions for the benefit to its
      employees, which plan has total assets in excess of $5,000,000;

     

    ____________   
      (vii) An
      employee benefit plan within the meaning of the Employee Retirement
      Income Security Act of 1974 (“ERISA”), if the investment decision is made by a
“Plan
      Fiduciary”, as defined in Section 3(21) of ERISA, which is either a bank,
      savings and loan association, insurance company or registered investment
      adviser;

     

    ____________   
      (viii) An
      employee benefit plan within the meaning of ERISA having total assets in excess
      of $5,000,000;

     

    ____________   
      (ix) A
      self-directed employee benefit plan within the meaning of ERISA,
      with investment decisions made solely by persons who are accredited investors
      as
defined
      in Rule 501(a) of Regulation D;

    
      
        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

    ____________   
      (x) A
      business development company (as defined in Section 2(a)(48) of
      the
      Investment Company Act) or a private business development company (as defined
      in
Section
      202(a)(22) of the Investment Advisers Act of 1940);

     

    ____________   
      (xi) A
      corporation, partnership, Massachusetts or similar business trust, or
      organization described in Section 501(c)(3) of the Internal Revenue Code of
      1986, as amended (tax exempt organization), not formed for the specific purpose
      of acquiring the Shares having total assets in excess of
      $5,000,000;

     

    ____________   
      (xii) Any
      executive officer or director of the Company;

     

    ____________   
      (xiii) An
      individual having an individual net worth or a joint net worth with
      spouse at the time of purchase in excess of $1,000,000;

     

    ____________   
      (xiv) An
      individual whose net income was in excess of $200,000 in each
      of
      the two most recent years, or whose joint income with spouse was in excess
      of
      $300,000 in
      each
      of those years, and who reasonably expects his net income to reach such level
      in
      the current
      year;

     

    ____________   
      (xv) A
      trust
      with total assets in excess of $5,000,000 not formed for the specific purpose
      of
      acquiring the Shares whose purchase is directed by a sophisticated person (i.e.,
      person who has such knowledge and experience in financial and business matters
      that he is capable of evaluating the merits and risks of any securities);
      or

     

    ____________   
      (xvi) Any
      entity in which all of the entity owners are “accredited
      investors.”

     

    (e) Subscriber's
      Financial Experience. Subscriber
      is sufficiently experienced in financial
      and business matters to be capable of evaluating the merits and risks of an
      investment in the Company or, if he or she has utilized the services of a
      purchaser representative, together with such representative, are sufficiently
      experienced in financial and business matter to be capable of evaluating the
      merits and risks of an investment in the Company. 

     

    (f) Suitability
      of Investment. Subscriber
      has evaluated the merits and risks of Subscriber's
      proposed investment in the Company, including those risks particular to
      Subscriber's situation,
      and has determined that this investment is suitable for Subscriber. Subscriber
      has adequate
      financial resources for an investment of this character, and at this time
      Subscriber can bear a complete loss of Subscriber's investment. Further,
      Subscriber will continue to have, after making an investment in Units, adequate
      means of providing for Subscriber's current needs, the needs
      of
      those dependent on Subscriber, and possible personal contingencies. Subscriber
      specifically
      represents that he or she has a net worth at least five times greater than
      the
      investment made
      herein.

     

    (g) Exempt
      Offering. Notwithstanding
      that the Company intends to register the Shares underlying
      the Units for resale, Subscriber understands that the sale of Units is not
      being
registered
      on the basis that this issuance is exempt from registration under the Securities
      Act, and the
      applicable state securities laws, and the rules and regulations promulgated
      thereunder, and that
      reliance on such exemptions is predicated, in part, on Subscriber's
      representations and warranties
      contained in this Agreement.

     

    (h) Limitations
      on Disposition. Subscriber
      understands that there are substantial restrictions
      on the transferability of the Shares underlying the Units pursuant to the
      Securities Act;
      the
      Shares underlying the Units will not be, and, except as provided in Section
      3
      herein, Subscriber has no right to require that the Shares underlying the Units
      be registered under the Securities Act; and, accordingly, Subscriber may have
      to
      hold the Shares underlying the Units for an indefinite period of time until
      the
      Shares underlying the Units have been registered by the Company or are subject
      to an exemption from registration. Subscriber represents that Subscriber can
      afford to hold the Shares underlying the Units for an indefinite period of
      time.
      Subscriber further
      understands that an opinion of counsel and other documents may be required
      to
      transfer the
      Shares underlying the Units. Subscriber acknowledges that the Shares underlying
      the Units shall bear the following, or a substantially similar,
      legend:

    
      
        
        

      

      
        5

        
          

        

      

      
        
        

      

    

     

    "THE
      SHARES OF COMMON STOCK REPRESENTED BY THIS CERTIFICATE
      HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
      OF
      1933, AS AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS AND
      NEITHER SUCH SHARES NOR ANY INTEREST THEREIN
      MAY BE OFFERED, SOLD, PLEDGED, ASSIGNED OR OTHERWISE
      TRANSFERRED UNLESS (1) A REGISTRATION STATEMENT
      WITH RESPECT THERETO IS EFFECTIVE UNDER THE SECURITIES ACT AND ANY APPLICABLE
      STATE SECURITIES LAWS, OR (2) IN ACCORDANCE WITH THE PROVISIONS OF REGULATION
      S,
      OR (3) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES
      ACT."

     

    (i) Absence
      of Official Evaluation. Subscriber
      understands that no federal or state agency
      has made any finding or determination as to the fairness of the terms of an
      investment in the Company, or any recommendation for or endorsement of the
      Units
      offered hereby.

     

    (j) Additional
      Financing. Subscriber
      further acknowledges that nothing hereunder shall preclude the Company from
      seeking and/or procuring additional equity and/or debt financing.

     

    (k) Non-reliance.
      Subscriber
      is not relying on the Company or any representation contained
      herein or in the documents referred to herein with respect to the tax and
      economic effect
      of
      Subscriber's investment in the Company.

     

    (l) Acceptance.
      Subscriber
      acknowledges that the Company shall, in its sole discretion, have the right
      to
      accept or reject this subscription, in whole or in part, for any reason or
      for
      no reason. If Subscriber’s subscription is accepted by the Company, Subscriber
      shall, and Subscriber hereby elects to, execute any and all further documents
      necessary in the opinion of the Company to complete his subscription and become
      a shareholder of the Company.

     

    (m) Authority
      to Enter into Agreement. Subscriber
      has the full right, power, and authority
      to execute and deliver this Agreement and perform Subscriber's obligations
      hereunder.

     

    (n) Entity
      as a Subscriber. If
      Subscriber is a corporation, partnership, trust, or other entity,
      (i) Subscriber is authorized and qualified to become a shareholder of, and
      is
      authorized to, make
      its
      investment in the Company; (ii) Subscriber has not been formed for the purpose
      of acquiring
      an interest in the Company; (iii) Subscriber has not been in existence for
      less
      than 90 days prior to the date hereof; and (iv) the person signing this
      Agreement on behalf of such entity has been duly authorized by such entity
      to do
      so.

     

    (o) Prohibitions
      on Cancellation, Termination, Revocation, Transferability, and Assignment.
      Subscriber
      hereby acknowledges and agrees that, except as may be specifically provided
      herein or by applicable law, Subscriber is not entitled to cancel, terminate,
      or
      revoke this
      Agreement, and this Agreement shall survive Subscriber's death or disability
      or
      any assignment
      of Units. Subscriber further agrees that Subscriber may not transfer or assign
      Subscriber's
      rights under this Agreement, and Subscriber understands that, if Subscriber's
      subscription
      is accepted, the transferability of Shares will be restricted.

     

    (p) Obligation.
      This
      Agreement constitutes a valid and legally binding obligation of Subscriber
      and
      neither the execution of this Agreement nor the consummation of the transactions
      contemplated
      herein will constitute a violation of or default under, or conflict with, any
      judgment, decree,
      statutes or regulation of any governmental authority applicable to Subscriber,
      or any contract,
      commitment, agreement, or restriction of any kind to which Subscriber is a
      party
      or by which Subscriber's assets are bound. The execution and delivery of this
      Agreement does not, and the consummation of the transactions described herein
      will not, violate applicable laws, or any mortgage, lien, agreement, indenture,
      lease or understanding (whether oral or written) of any kind outstanding
      relative to Subscriber.

    
      
        
        

      

      
        6

        
          

        

      

      
        
        

      

    

     

    (q) Required
      Approvals. No
      approval, authorization, consent, order, or other action of, or filing with,
      any
      person, firm or corporation or any court, administrative agency or other
governmental
      authority is required in connection with the execution and delivery of this
      Agreement
      by Subscriber or the purchase of the Units.

     

    (r) No
      General Solicitation. Subscriber
      is not subscribing for Units because of or following
      any advertisement, article, notice, or other communication published in any
      newspaper, magazine or similar media or broadcast over television or radio,
      or
      presented at any seminar or meeting, or any solicitation or a subscription
      by a
      person other than an authorized representative of the Company.

     

    3.
      Representations, Warranties and Agreements of the Company. In
      connection with
      this
      subscription, the Company makes the following representations, warranties and
      agreements
      and confirms the following understandings:

     

    (a) Company's
      Good Standing. The
      Company is a corporation organized and validly existing under the laws of the
      State of Nevada, and it has all corporate authority and power to conduct its
      business and to own its properties.

     

    (b) Legal
      and Other Proceedings. Neither
      the Company, nor any of its affiliates or its executive
      officers or directors (in their capacity as executive officers or directors),
      is
      a party to any
      pending or, to the best knowledge of the Company, threatened, or unasserted
      but
      considered by it to be probable of assertion, claim, action, suit,
      investigation, arbitration or proceeding, or is subject
      to any order, judgment or decree that is reasonably expected by management
      of
      the Company
      to have, either individually or in the aggregate, a material adverse effect
      on
      the condition
      (financial or otherwise), earnings or results of operations of the Company.
      The
Company
      is not, as of the date hereof, a party to or subject to any enforcement action
      instituted by,
      or
      any agreement or memorandum of understanding with, any federal or state
      regulatory authority
      restricting its operations or requiring that actions be taken, and no such
      regulatory authority
      has threatened any such action, memorandum or order against the Company and
      the
      Company has not received any report of examination from any federal or state
      regulatory agency which requires that the Company address any problem or take
      any action which has not already been addressed or taken in a manner
      satisfactory to the regulatory agency.

     

    (c) Authorization;
      Conflict; Valid and Binding Obligation. This
      Agreement and the transactions contemplated herein have been duly and validly
      authorized by all requisite corporate action of the Company. The Company has
      full right, power and capacity to execute, deliver and perform its obligations
      under this Agreement. No governmental license, permit or authorization
and
      no
      registration or filings with any court, governmental authority or regulatory
      agency is required
      in connection with the Company's execution, delivery and/or performance of
      this
Agreement,
      other than any filings required by applicable federal and state securities
      laws.
      The execution, delivery and performance of this Agreement, the consummation
      of
      the transactions herein contemplated and the compliance with the terms of this
      Agreement by the Company will not violate or conflict with any provision of
      the
      Articles of Incorporation, as amended or By-laws of
      the
      Company, or any agreement, instrument, law or regulation to which the Company
      is
      a party or
      by
      which the Company may be bound. This Agreement, upon execution and delivery
      by
      the Company,
      will represent the valid and binding obligation of the Company enforceable
      in
accordance
      with its terms.

     

    (d) Use
      of Proceeds. The
      Company will be using the funds raised in this Offering for general working
      capital and to pursue its business plan, including, but not limited to, further
      product development and market launch, marketing, advertising, hiring and
      repayment of existing debt.

    
      
        
        

      

      
        7

        
          

        

      

      
        
        

      

    

     

    4. Survival
      of Representations, Warranties, Agreements and Acknowledgments.
The
      representations, warranties, agreements, and acknowledgments of the Company
      and
Subscriber
      shall survive the offering and purchase of Units.

     

    5. Indemnification
      of the Company. Subscriber
      agrees to indemnify and hold harmless
      the Company against and in respect of any and all loss, liability, claim,
      damage, deficiency,
      and all actions, suits, proceedings, demands, assessments, judgments, costs
      and
expenses
      whatsoever (including, but not limited to, attorneys' fees reasonably incurred
      in investigating,
      preparing, or defending against any litigation commenced or threatened or any
      claim
      whatsoever through all appeals) arising out of or based upon any false
      representation or warranty or breach or failure by Subscriber to comply with
      any
      covenant or agreement made by it herein or in any other document furnished
      by it
      in connection with this subscription.

     

    6. Miscellaneous.

     

    (a) Entire
      Agreement. This
      Agreement together with the Warrant Agreement, the Warrants and the Convertible
      Notes contemplated herein constitutes the entire agreement between the
parties
      hereto, and supersedes all prior negotiations, letters and understandings
      relating to the subject
      matter hereof.

     

    (b) Amendments.
      This
      Agreement may not be amended, supplemented, or modified in whole or in part
      except by an instrument in writing signed by the party or parties against whom
      enforcement of any such amendment, supplement, or modification is
      sought.

     

    (c) Notices.
      Any
      notice, demand, or other communication that any party hereto may be required,
      or
      may elect, to give to anyone interested hereunder shall be deemed given on
      the
      date initially received if delivered by facsimile transmission followed by
      registered or certified mail confirmation;
      on the date delivered by an overnight courier service; on the third business
      day
after
      it
      is mailed if mailed by registered or certified mail (return receipt requested,
      with postage and
      other
      fees prepaid) addressed to such addresses as provided herein.

     

    (d) Successors
      and Assigns. Except
      as
      otherwise provided herein, this Agreement shall be binding upon and inure to
      Subscriber’s benefit and the benefit of Subscriber’s heirs, executors,
administrators,
      successors, legal representatives, and permitted assigns. If the undersigned
      is
      more than
      one
      person, the obligation of the undersigned shall be joint and several and the
      agreements, representations, warranties, and acknowledgements herein contained
      shall be deemed to be made by
      and be
      binding upon each such person and his heirs, executors, successors,
      administrators, legal
      representatives, and permitted assigns.

     

    (e) Choice
      of Law; Venue. This
      Agreement will be interpreted, construed, and enforced in
      accordance with the laws of the State of New York, without giving effect to
      the
      application of the principles pertaining to conflicts of laws. Any proceeding
      arising between the parties in any manner pertaining or relating to this
      Agreement shall, to the extent permitted by law, be held in New
      York.

     

    (f) Effect
      of Waiver. The
      failure of any party at any time or times to require performance
      of any provision of this Agreement will in no manner affect the right to enforce
      the same. The waiver by any party of any breach of any provision of this
      Agreement will not be construed to be a waiver by any such party of any
      succeeding breach of that provision or a waiver by such party of any breach
      of
      any other provision.

    
      
        
        

      

      
        8

        
          

        

      

      
        
        

      

    

     

    (g) Severability.
      The
      invalidity, illegality, or unenforceability of any provision or provisions
      of this Agreement will not affect any other provision of this Agreement, which
      will remain
      in
      full force and effect, nor will the invalidity, illegality, or unenforceability
      of a portion of
      any
      provision of this Agreement affect the balance of such provision. In the event
      that any one or more of the provisions contained in this Agreement or any
      portion thereof shall for any reason be held to be invalid, illegal, or
      unenforceable in any respect, this Agreement shall be reformed, construed,
      and
      enforced as if such invalid, illegal, or unenforceable provision had never
      been
      contained herein.

     

    (h) Enforcement.
      Should
      it
      become necessary for any party to institute legal action to enforce this
      Agreement, the successful party will be awarded reasonable attorneys' fees
      at
      all trial and appellate levels, expenses, and costs.

     

    (i) Counterparts.
      This
      Agreement may be executed in one or more counterparts, each of
      which
      will be deemed an original and all of which together will constitute one and
      the
      same instrument.

     

    (j) Further
      Assurances. The
      parties hereto will execute and deliver such further instruments
      and do such further acts and things as may be reasonably required to carry
      out
      the intent and purposes of this Agreement.

     

    [SIGNATURES
      ON THE FOLLOWING PAGE]

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

    Herborium
      Group, Inc.

     

    SUBSCRIPTION
      AGREEMENT

     

    SIGNATURE
      PAGE FOR INDIVIDUALS

     

    IN
      WITNESS WHEREOF, the
      undersigned has caused this Agreement to be executed as of
      the day
      of
      __________,
      200__________.

     

    Total
      Number of Units Subscribed for:_____________ Total Purchase Price:
      $_________________

    

     

    
      	
               

            	
               

            	 	
               

            
	 	
              (Signature
                of Subscriber)

            	 	
              (Signature
                of Spouse or Joint Tenant, If Any)

            
	 	 	 	 
	
               

            	
               

            	 	
               

            
	 	
              (Print
                Name of Subscriber)

            	 	
              (Print
                Name of Spouse or Joint Tenant, If Any)

            
	
               

            	
               

            	 	
               

            
	 	
              (Address)

            	 	
              (Address)

            
	
               

            	
               

            	 	
               

            
	 	
              (Telephone
                Number)

            	 	
              (Telephone
                Number)

            
	
               

            	
               

            	 	
               

            
	 	
              (Social
                Security Number)

            	 	
              (Social
                Security Number)

            
	
               

            	
               

            	 	
               

            
	 	
              (Date)

            	 	
              (Date)

            

    

     

    Note:
      If
      two
      purchasers are signing, please check the manner in which the ownership is
to
      be
      legally held (the indicated manner shall be construed as if written out in
      full
      accordance with
      applicable laws or regulations):

     

    
      _____ 
        JT TEN:  As
        joint
        tenants with right of survivorship and not as tenants in common.

    

     

    _____ 
      TEN
      COM:
 As
      tenants in common.

     

    _____ 
      TENENT:  As
      tenants by the entireties.

     

    The
      undersigned hereby tenders to, the amount above indicating the number of Units
      of Herborium Group, Inc.
      subscribed for. Checks should be made payable to
      _______________________________________.
      Wire
      transfer information is available upon request.

    
      
        
        

      

      
        10

        
          

        

      

      
        
        

      

    

    Herborium
      Group, Inc.

     

    SUBSCRIPTION
      AGREEMENT

    SIGNATURE
      PAGE FOR CORPORATIONS, TRUSTS, PARTNERSHIPS OR RETIREMENT
      PLANS

     

    IN
      WITNESS WHEREOF, the
      undersigned has caused this Agreement to be executed as of
      the
      __________day of__________________, 200__________.

     

    Total
      Number of Units Subscribed for:______________ Total Purchase Price:
      $_______________

    

     

    
      

    

    (Signature
      of Subscriber)

     

    
      

    

    (Print
      Name of Subscriber)

     

     

    
      

    

    
      (Address)

       

    

    
      

    
      (Telephone
        Number)

       

    

    
      

    

    
      (Social
        Security Number)

       

    

    
      

      (Date)

       

    

    
      

    

    
      (Federal
        Employer Identification Number or Other
        Tax

    

    Identification
      Number)

     

    The
      undersigned hereby tenders to, the amount above indicating the number of Units
      Herborium Group, Inc. subscribed for. Checks should be made payable to
      _________________________________________________.
      Wire
      transfer information is available upon request.

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

    Herborium
      Group, Inc.

     

    APPROVED
      AND ACCEPTED in
      accordance with the terms of this Subscription Agreement on this _______ day
      of___________________, 200________.

     

     

    
      	 	
              By:
                

            	 

              

            
	 	 	 
	 	 	 
	 	
              Name:

            	 

              

            
	 	
              Title:

            	 

              

            

    

     

    
      
        
        

      

      
        12

        
          

        

      

      
        
        

      

    

     

    EXHIBIT
      A

     

    SUMMARY
      TERM SHEET

     

    This
      term
      sheet summarizes the principal terms of the proposed bridge financing of
      Herborium Inc. (the “Company”)
      of
      Convertible Promissory Notes (“Notes”),
      together with common shares (“Common
      Stock”)
      and
      warrants to purchase certain securities of the Company (“Warrants”).
      This
      term sheet has been incorporated by reference into the Company’s subscription
      agreement and as such does not constitute either an offer to sell or an offer
      to
      purchase securities on a standalone basis.

     

    
      	
              Issuer:

               

            	
              Herborium
                Group, Inc. (the “Company”)
                

               

            
	
              Securities:

               

            	
              Issued
                in Units (“Unit”), each unit consisting of; $50,000 Face Value Promissory
                Notes, 50,000 shares of the Company’s Common Stock and Warrants to
                Purchase 100,000 shares of the Company’s Common Stock 

               

            
	
              Financing
                Amount:

               

            	
              Up
                to $500,000 in aggregate principal amount of Notes to be funded in
                tranches provided that the principal amount of each tranch shall
                not be
                less than $50,000. The closing date of each tranch is referred to
                as the
                Funding Date. The Company may elect to accept up to an additional
                $250,000
                in principal amount of Notes under an over-allotment
                option.

            
	 	 
	
              Use
                of Proceeds:

            	
              The
                net proceeds of the Offering (after legal, placement and other fees)
                will
                be used for further product development and market launch, marketing,
                advertising, human resources hiring and for general recurring working
                capital purposes, including the payment of accrued working capital
                items
                and general corporate payables. No proceeds will be used for the
                repayment
                of any existing debt other than accrued accounts payable, and no
                payment
                will made from these proceeds on any shareholder/officer
                loans.

            
	 	 
	
              Documents:

            	
              The
                investment shall be made pursuant to a Note, Common Stock and Warrant
                Purchase Agreement. Investors will complete subscription documents
                and
                accredited purchaser questionnaires.

            
	
               

              The
                Notes:

            	 
	
              Maturity
                Date:

            	
              All
                principal and interest on the Notes will be due and payable upon
                the
                earlier of (i) upon demand made any time after the date that is 12
                months
                from initial issuance of a Note (the “Target
                Date”),
                (ii) the date upon which the Company completes the sale of Common
                Stock
                (or like security) for aggregate gross proceeds of at least $1.5
                million
                (a “Qualified
                Financing”),
                or (iii) the closing of an acquisition of the Company, whether by
                material
                merger, reorganization, sale of assets or other similar material
                transaction (an “Acquisition”).

            
	 	 
	
              Applicable
                Interest:

               

            	
              Interest
                shall accrue on all outstanding principal amounts of the Notes at
                a rate
                of 10 % per annum based on a 365-day year. Interest shall be due
                and
                payable semi-annually, in arrears.

            

    

    
      
        
        

      

      
        i

        
          

        

      

      
        
        

      

    

    

    
      	
              Interest

               

            	
              Payable
                in kind at a price equal to $0.025 per share

               

            
	
              Conversion:

               

            	
              1. At
                the Note holder’s option all, or a portion of, the principal and accrued
                interest on the Notes may be converted into shares after six (6)
                months
                from closing, at $0.025 per share, or

               

              2. At
                the Note holder’s option all, or a portion of, the principal and accrued
                interest on the Notes may be converted into shares of Common Stock
                issued
                in a Qualified Financing at the closing of a Qualified Financing
                or
                Acquisition (determined as if such conversion were gross proceeds
                to the
                Company of such financing). The number of shares into which the Notes
                are
                convertible into will equal the quotient of the converted principal
                and
                interest divided by the price per share issued in the Qualified Financing
                at a 20% discount, or

               

            
	
              Equal
                Treatment of

              Holders:

            	
              No
                payments of principal or interest shall be made on any Note unless
                such
                payment is made pro-rata to all holders of the Notes.

               

            
	
              Transfer
                Restrictions:

            	
              The
                Notes will not be transferable without the prior written consent
                of the
                Company.

            
	 	 
	
              Automatic
                Principal

              Redemption:

            	
              Subject
                to the following, the Notes will be automatically redeemed by the
                Company
                on a pro-rata basis. To the extent that the Company generates revenues
                the
                holders of the Notes shall receive re-payment of a portion of their
                investment amount at the end of each semi-annual period until they
                have
                received their entire investment amount plus any unpaid interest.
                In order
                to provide for such redemption, the Company will place five percent
                (5.0%)
                of the gross revenues derived by the Company into a separate bank
                account
                (the “Redemption Funds”). The Redemption Funds will be distributed
                pro-rata among the holders of the Notes within thirty (30) business
                days
                after the end of each semi-annual period. Funds paid to holders shall
                first be applied to any unpaid
                principal.

            

    

    
      
        
        

      

      
        ii

        
          

        

      

      
        
        

      

    

    

    
      	
              The
                Warrants:

            	 
	
              Shares
                Underlying

              Warrants:

               

            	
              The
                Warrants will be exercisable for shares of Common Stock.

               

            
	
              Number
                of Shares:

               

               

            	
              For
                each Unit purchased, the Holder will receive 100,000 Warrants to
                purchase
                100,000 shares of the Company’s Common Stock. 

               

            
	
              Exercise
                Price:

               

            	
              Each
                Unit will consist of:

               

              50,000
                Warrants at an exercise price of $0.025 per share. 

              50,000
                Warrants at an exercise price of $0.05 per share.

               

            
	
              Exercise
                Period:

               

            	
              The
                Warrants may be exercised at anytime within five (5) years from the
                date
                of issuance.

               

            
	
              Transfer
                Restrictions:

               

            	
              The
                Warrants will not be transferable without the prior written consent
                of the
                Company.

               

            
	
              Registration
                Rights:

               

            	
              The
                Common Stock underlying the Warrants will have “piggyback” rights in the
                next Registration filed by the Company

            
	
              The
                Common Stock:

            	 
	
              Shares:

               

            	
              Company
                Common Stock.

               

            
	
              Number
                of Shares:

            	
              For
                each Unit purchased, the Holder will receive 50,000 shares of the
                Company’s Common Stock.

            
	 	 
	
              Registration
                Rights:

               

            	
              The
                Common Stock will have “piggyback” rights in the next Registration filed
                by the Company.

               

            
	
              Placement
                Agent

            	
              Southridge
                Investment Group is acting as the Company’s Placement Agent. Southridge
                will receive a cash placement fee equal to 10% of all proceeds from
                this
                financing as well as 2% expense allowance. Southridge will also receive
                common stock purchase warrants exercisable for a number of shares
                of
                Common Stock equal to 8% of the shares issues and shares issuable
                upon
                conversion of the Notes and exercise of the warrants. The exercise
                price
                of these placement agent warrants will be 110% of the exercise price
                of
                the Warrants issued to investors. Southridge will also receive 750,000
                shares of the Common Stock as a retainer for its general services
                as the
                Company’s financial advisor, and up to 500,000 shares as an additional
                financial advisory fee in connection with this
                financing.

            

    

     

    
      
        
        

      

      
        iii

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00137-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00137-of-00352.parquet"}]]